PolyHeme FDA Approval Status
FDA Approved: No
Brand name: PolyHeme
Generic name: human hemoglobin
Company: Northfield Laboratories Inc.
Treatment for: Bleeding Disorder
PolyHeme is a human hemoglobin-based red cell substitute for the treatment of life-threatening red blood cell loss when an oxygen-carrying fluid is required and red blood cells are not available.
Development timeline for PolyHeme
|May 1, 2009||Northfield Receives Complete Response Letter for PolyHeme BLA|
|Dec 30, 2008||BLA for PolyHeme Accepted for Filing and Granted Priority Review|
|Oct 29, 2008||Northfield Laboratories Inc. Announces Submission of BLA for PolyHeme|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.